Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Current Assets (2020 - 2026)

Nuvalent's (NUVL) quarterly Current Assets came in at $1.3 billion in Q1 2026, up 20.37% YoY from $1.1 billion in Q1 2025, and down 6.07% on a QoQ basis from $1.4 billion in Q4 2025.

Analysis

Nuvalent (NUVL) Current Assets (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of Current Assets data on file, last reported at $1.3 billion in Q1 2026.

  • Quarterly Current Assets rose 20.37% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 20.37% YoY) and the FY2025 annual result came in at $1.4 billion, up 22.96% from the prior year.
  • Current Assets declined to $1.3 billion in Q1 2026, from $1.4 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.4 billion in Q4 2025 to a low of $245.2 million in Q3 2022.
  • A 5-year average of $749.3 million and a median of $699.5 million in 2024 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2022 — Current Assets fell 19.63% — and 2024, when it surged 181.03%.
  • Tracing NUVL's Current Assets over 5 years: stood at $478.0 million in 2022, then jumped by 51.99% to $726.5 million in 2023, then jumped by 55.88% to $1.1 billion in 2024, then increased by 22.96% to $1.4 billion in 2025, then declined by 6.07% to $1.3 billion in 2026.
  • The last three Current Assets figures came in at $1.3 billion (Q1 2026), $1.4 billion (Q4 2025), and $956.9 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.82 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.03 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7.22 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.62 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.76 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.63 Bn
10 Nuvalent 9.75 Bn 9.75 Bn - 1.31 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.31 Bn
Dec 31, 2025 1.39 Bn
Sep 30, 2025 956.95 Mn
Jun 30, 2025 1.02 Bn
Mar 31, 2025 1.09 Bn
Dec 31, 2024 1.13 Bn
Sep 30, 2024 1.18 Bn
Jun 30, 2024 666.26 Mn
Mar 31, 2024 699.49 Mn
Dec 31, 2023 726.49 Mn
Sep 30, 2023 419.77 Mn
Jun 30, 2023 436.99 Mn
Mar 31, 2023 456.29 Mn
Dec 31, 2022 477.99 Mn
Sep 30, 2022 245.25 Mn
Jun 30, 2022 258.82 Mn
Mar 31, 2022 274.47 Mn
Dec 31, 2021 290.63 Mn
Sep 30, 2021 305.14 Mn
Jun 30, 2021 139.28 Mn